Welcome to

TARGEDYS

Our mission is to control metabolic disease by modulating the appetite through an intervention
  on the microbiome.

My dear homeland, I know you are suffering and in pain I know it is hard for you because strangers burn you and seek your destruction But your real children who are looking to build you are very hard but with full courage trying to pull you out of these bad days

Probiotic Strain H. alvei HA4597® Improves Weight Loss in Overweight Subjects: Multicenter Randomized, Double-Blind Placebo-Controlled Study www.mdpi.com/1133608  via @MDPIOpenAccess #microbiome #hafnia #probiotic #precibiomic #weight #glycemia #HA4597They talk about us ! @PourlaScience talks about the role of the #ClpB protein in regulating appetite via the #gut-#brain axis.

Choix multiples :

Choix unique :

WHO ARE WE?

OUR UNIQUE APPROACH

Is to use the concept of molecular mimicry to physiologically bind well-described pharmacological targets with bacterial metabolites and derived small molecules

TargEDys® translates its unique understanding of the gut-brain axis to develop and manufacture nutritional and therapeutic solutions to control metabolic diseases. The company aims to be at the forefront of safe and effective weight management to improve the health and life quality of many over and underweight people.

The TargEDys research team at the INSERM lab of Rouen University has identified a novel mechanism of appetite regulation involving bacterial, hormonal mimetic, proteins that are found naturally in the gut microbiome. This mechanism acts as the basis of TargEDys’ two technologies: ProbioSatys™ and ProbioNutrys™, which respectively moderate the appetite of overweight people and restore the appetite of elderly, cachexic or anorexic people.

armm

OUR FOCUS

Overweight

1.4B

people (>20yrs) are overweight
(WHO, 2009)

5th

biggest risk factor for
 death is obesity
(WHO, 2014)

50%

of the population in France are overweight
(INVS, 2016)

70%

of the US population are affected by obesity and overweight
(OECD, 2017)

13%

of the worldwide adult population are obese
(The Lancet, 2016)

Underweight

70M

people worldwide suffering from eating disorders
(Renfrew, 2003)

3ème

most common chronic illness for adolescents is anorexia
(Yeo&Hughes, 2011)

50-80%

of cancer patients
are affected
by cachexia
(Anker, 2014)

20%

of cancer deaths
are caused
by cachexia
(Takabe, 2015)

30-60%

of elderly
people are
undernourished
(Bozzetti, 2010)

OUR TIMELINE

TimelineGB
This website uses different types of cookies to enable, improve and monitor the use of our website. For more information see our cookie policy
By clicking accept or continuing to browse on our website, you consent to the use on your device of analytics, advertising and other tags/files.
Read about